跳至主要内容
临床试验/DRKS00025154
DRKS00025154已完成未知

Exposure therapy in virtual reality addressing public speaking anxiety in order increase willingness for in vivo exposure in patients with anxiety disorder and obsessive-compulsive disorder - Expo-VR-Wil

niversitätsklinikum Hamburg-Eppendorf0 个研究点目标入组 90 人开始时间: 2021年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Obsessive-Compulsive Disorder and/or anxiety disorder (MINI criteria)
  • Gender: male, female
  • Minimum Age: 18 Years
  • Maximum Age: 75 Years
  • Consent to participate in a single VR-session and the diagnostic interviews
  • Ability to give consent
  • Sufficient understanding of the German language

排除标准

  • Psychotic symptoms (current or lifetime)
  • Severe neuropsychological disease
  • Current substance dependence
  • Physical illnesses that are a contraindication to exposures (e.g. heart disease)

研究者

发起方
niversitätsklinikum Hamburg-Eppendorf

相似试验

Exposure therapy in virtual reality addressing... | 临床试验